title: Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy.
abstract: OBJECTIVE
  We describe a case demonstrating a submacular deposition of triamcinolone acetonide (TA) after a TA-assisted vitrectomy for retinal detachment.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A 48-year-old Japanese man with rhegmatogenous retinal detachment in his left eye underwent a TA-assisted vitrectomy, endolaser photocoagulation, and sulfur hexafluoride (SF(6)) gas tamponade.
  
  
  RESULTS
  At the end of the surgery and the day after undergoing vitrectomy, the deposition of TA was observed between the retinal pigment epithelium and neurosensory retina in the submacular area. These TA granules disappeared after 2 weeks. Two months after the operation, the retina was observed to be successfully attached and no abnormality was observed in the macula. The patient's visual acuity improved to 20/16, and no ophthalmoscopic or functional damage was observed.
  
  
  CONCLUSIONS
  No apparent adverse effect was found in this case demonstrating a submacular deposition of TA.
authors.affiliation: Department of Ophthalmology, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Enaida
authors.forename: Taiji
authors.initials: T
authors.lastname: Sakamoto
authors.forename: Akifumi
authors.initials: A
authors.lastname: Ueno
authors.forename: Takao
authors.initials: T
authors.lastname: Nakamura
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Noda
authors.forename: Keiko
authors.initials: K
authors.lastname: Maruoka
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Ishibashi
mesh_terms: D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000187:drug effects*; D012163:Retinal Detachment / Q000188:drug therapy* / Q000601:surgery*; D012449:Safety; D013459:Sulfur Hexafluoride / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods*
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide; D013459:Sulfur Hexafluoride